Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies
Clinical trial NCT02912845 · COMPLETED
Trial details
- NCT number
- NCT02912845
- Sponsor
- Kamada, Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2019-11-13
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.